Advertisement

Topics

Emotional Perceptual Training as a Treatment for Social Anxiety: Behavioral and Neural Evidence.

2018-02-22 19:05:23 | BioPortfolio

Published on BioPortfolio: 2018-02-22T19:05:23-0500

Clinical Trials [1837 Associated Clinical Trials listed on BioPortfolio]

Prevalence of Psychological Disorders After Immediate Postpartum Hemorrhage

The objective of this cross-sectional study is to assess the prevalence of depression at 2 months, 6 months, and 1 year postpartum in women who had an immediate postpartum hemorrhage (imme...

Cognitive Behavioural Therapy for Anxiety Disorders in PD

Anxiety disorders occur in up to 35% of patients with Parkinson's disease (PD) and have a negative effect on gait, dyskinesia, freezing, on/off fluctuations, and quality of life. With this...

Evaluating a Personalized Trans-Diagnostic Group Therapy for Anxiety

This study is examining the impact of a therapy group for all anxiety disorders provided by the Stanford Department of Psychiatry and Behavioral Sciences's Psychosocial Treatment Clinic on...

Evaluating Parenting Styles and Child Temperament Associated With Child Anxiety Disorders

This study will look at similarities and differences in family processes and child temperament among children with and without symptoms of anxiety disorders.

Initial Severity and Antidepressant Efficacy for Anxiety Disorders: an Individual Patient Data Meta-analysis

Anxiety disorders are common disorders, which pose a major burden to society and the individual. An anxiety disorder may be treated with medication, in particular with antidepressants such...

PubMed Articles [12517 Associated PubMed Articles listed on BioPortfolio]

Shame-proneness, guilt-proneness and anxiety symptoms: A meta-analysis.

There is a growing body of investigations showing that shame and guilt are important features of various psychological problems including anxiety disorders. This study quantitatively summarized the ma...

Impaired discriminative fear conditioning during later training trials differentiates generalized anxiety disorder, but not panic disorder, from healthy control participants.

Fear conditioning is implicated as a central psychopathological mechanism of anxiety disorders. People with anxiety disorders typically demonstrate reduced affective discrimination between conditioned...

Gender-specific associations of depression and anxiety symptoms with mental rotation.

Men score higher on mental rotation tasks compared to women and suffer from depression and anxiety at half the rate of women. The objective of this study was to confirm the gender-specific effects of ...

Anxiety Partially Mediates Cybersickness Symptoms in Immersive Virtual Reality Environments.

The use of virtual reality (VR) in psychological treatment is expected to increase. Cybersickness (CS) is a negative side effect of VR exposure and is associated with treatment dropout. This study aim...

Gender differences in longitudinal relationships between depression and anxiety symptoms and inflammation in the health and retirement study.

Depression and anxiety have been linked to elevated inflammation in cross-sectional and longitudinal studies. Yet, in terms of longitudinal studies, findings are inconsistent regarding whether depress...

Medical and Biotech [MESH] Definitions

Prejudice or discrimination based on gender or behavior or attitudes that foster stereotyped social roles based on gender.

Anxiety disorders manifested by the development of characteristic symptoms following a psychologically traumatic event that is outside the normal range of usual human experience. Symptoms include re-experiencing the traumatic event, increased arousal, and numbing of responsiveness to or reduced involvement with the external world. Traumatic stress disorders can be further classified by the time of onset and the duration of these symptoms.

Mental disorders related to sexual dysfunction, paraphilias, and gender identity disorders.

Training or retraining of the buccal, facial, labial, and lingual musculature in toothless conditions; DEGLUTITION DISORDERS; TEMPOROMANDIBULAR JOINT DISORDERS; MALOCCLUSION; and ARTICULATION DISORDERS.

A serotonin uptake inhibitor that is used as an antidepressive agent. It has been shown to be effective in patients with major depressive disorders and other subsets of depressive disorders. It is generally more useful in depressive disorders associated with insomnia and anxiety. This drug does not aggravate psychotic symptoms in patients with schizophrenia or schizoaffective disorders. (From AMA Drug Evaluations Annual, 1994, p309)

More From BioPortfolio on "Emotional Perceptual Training as a Treatment for Social Anxiety: Behavioral and Neural Evidence."

Advertisement
Quick Search
Advertisement
Advertisement

 

Searches Linking to this Trial